BRNS(BRNS)
BRNS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $738,662 | — |
| Low | $738,662 | — |
| High | $738,662 | — |
| EBITDA Avg | $-278,306 | — |
| Low | $-278,306 | — |
| High | $-278,306 | — |
| EBIT Avg | $-292,592 | — |
| Low | $-292,592 | — |
| High | $-292,592 | — |
| Net Income Avg | $-56M | $-59M |
| Low | $-56M | $-59M |
| High | $-56M | $-59M |
| EPS Avg | $-1.37 | $-1.46 |
| Low | $-1.37 | $-1.46 |
| High | $-1.37 | $-1.46 |
| Analysts (Rev / EPS) | 1 / 1 | — / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $216,900 | $867,500 | — | — | — | — |
| Low | $216,900 | $867,500 | — | — | — | — |
| High | $216,900 | $867,500 | — | — | — | — |
| EBITDA Avg | $-81,721 | $-326,848 | — | — | — | — |
| Low | $-81,721 | $-326,848 | — | — | — | — |
| High | $-81,721 | $-326,848 | — | — | — | — |
| EBIT Avg | $-85,916 | $-343,627 | — | — | — | — |
| Low | $-85,916 | $-343,627 | — | — | — | — |
| High | $-85,916 | $-343,627 | — | — | — | — |
| Net Income Avg | $-12M | $-13M | $-15M | $-15M | $-15M | $-15M |
| Low | $-12M | $-13M | $-15M | $-15M | $-15M | $-15M |
| High | $-12M | $-13M | $-15M | $-15M | $-15M | $-15M |
| EPS Avg | $-0.29 | $-0.31 | $-0.37 | $-0.37 | $-0.36 | $-0.36 |
| Low | $-0.29 | $-0.31 | $-0.37 | $-0.37 | $-0.36 | $-0.36 |
| High | $-0.29 | $-0.31 | $-0.37 | $-0.37 | $-0.36 | $-0.36 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | — / 1 | — / 1 | — / 1 | — / 1 |